MedTrace Logo

Comparison of Efficacy of Double Dose Oral Terbinafine Vs Itraconazole in Treatment of Dermatophyte Infections of Skin.

NCT04880980 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2022-04-01

No results posted yet for this study

Summary

Study would be conducted to compare the efficacy and safety of double than usual dose oral terbinafine versus itraconazole in treatment of dermatophyte infections of skin in patient presenting at dermatology department of Pak Emirates Military Hospital, Rawalpindi, Pakistan.

Conditions

  • Dermatophyte Infection
  • Terbinafine Adverse Reaction
  • Itraconazole Adverse Reaction

Interventions

DRUG

Terbinafine Pill

Double than usual dose of oral terbinafine pills will be used for treatment purpose in one group.

DRUG

Itraconazole capsule

Double than usual dose of oral itraconazole capsules will be used for treatment purpose in second group.

Sponsors & Collaborators

  • Pak Emirates Military Hospital

    lead OTHER

Principal Investigators

  • Dr. Umar Abdul Ali Qureshi, MBBS · Pak Emirates Military Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-15
Primary Completion
2022-03-15
Completion
2022-03-15

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04880980 on ClinicalTrials.gov